FindTrial
Sign In

Comparative study between injecting local anesthetic Ropivacaine 0.2 percent and Bupivacaine 0.25 percent in the chest wall fascial plane for Post-operative Analgesia in patients undergoing upper abdominal surgeries

Comparison of external oblique intercostal plane block with Ropivacaine 0.2 percent and Bupivacaine 0.25 percent for postoperative pain management in upper abdominal surgeries - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080575
Enrollment
30
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: External Oblique Intercostal Fascial Plane block with Ropivacaine 0.2%: Use of Ropivacaine 0.2% for post operative pain management in upper abdominal surgeries. To study pain score on V

Sponsors

Dr Darshan Vegada
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult patients scheduled for elective upper abdominal surgeries. 2 Patients who have given informed valid written consent 3 ASA GRADE I AND II

Exclusion criteria

Exclusion criteria: 1 Adult patients scheduled for emergency upper abdominal surgeries. 2 All patients who are not willing for the study 3 Skin infection at the puncture site. 4 Allergic to Local Anesthetic agents. 5 Pregnant female patients 6 Patient with coagulopathy

Design outcomes

Primary

MeasureTime frame
To assess the duration and quality of analgesia provided by ropivacaine 0.2% and bupivacaine 0.25% in external oblique intercostal plane block for upper abdominal surgeries by pain scores on Visual Analogue Score (VAS) post operatively .Timepoint: Visual Analogue Score (VAS) will be observed at 2 hours, 4 hours,6 hours, 8 hours, 12 hours, 16 hours, 20 hours and 24 hours interval.—

Secondary

MeasureTime frame
1 To asses and compare the opioid consumption between patients receiving ropivacaine 0.2% and bupivacaine 0.25% for external oblique intercostal plane block in 24 hours. 2 To determine the incidence of adverse effects associated with ropivacaine 0.2% and bupivacaine 0.25% in external oblique intercostal plane block. Timepoint: Visual Analogue Score (VAS) will be observed at 2 hours, 4 hours,6 hours, 8 hours, 12 hours, 16 hours, 20 hours and 24 hours interval.—

Countries

India

Contacts

Public ContactDr Darshan Vegada

D Y PATIL MEDICAL COLLEGE AND RESEARCH INSTITUTE

kadamsandeeps@gmail.com9922447500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026